Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin detemir versus NPH for body fat distribution in overweight or obese adults with type 2 diabetes
2008-003739-19Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin detemir, human insulin and insulin aspart in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Change in trunk fat mass. Started Sep 2008; status: completed.
02
Drugs
insulin detemirhuman insulininsulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-003739-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003739-19.